“The product segment is expected to account for the largest share of the human microbiome market in the coming years. The high growth in this segment is attributed to the expectations to bring promising microbiome products to the market to help individual for the treatment of chronic diseases and various disorders at early stages and also due to increased curiosity among people to stay fit and have healthy lifestyle. The ability of these products to combat the fatal lifestyle diseases and maintain good health among the diseased population with the use of effective microbiome-based drugs and diagnostics devices will influence the market growth.
Europe currently forms the largest human microbiome market in terms of demand for prebiotics and probiotics. The APAC region is expected to register the highest growth rate due to its immense growth opportunities and manufacturing cost benefits, while the U.S. is comparatively underdeveloped. Scientific evidence of health benefits of certain ingredients such as probiotics, prebiotics, etc. and the search for new opportunities to add value to the existing products are also expected to propel the global market growth. The demand for prebiotics and probiotics is increasing across various regions owing to the awareness among consumers regarding the favorable benefits of the microbiome community also referred as “friendly†bacteria. Most of the consumers prefer these products for maintaining good health and to use enhanced efficiency of ingredients, which offer products with bio-therapeutic properties. With the advancement in technology, the usage of probiotics is likely to extend beyond the current arena of gut, dental, and immune health to several other areas of human health.
Moreover, rising incidences of cardiac diseases and other diseases such as diabetes and obesity are also expected to contribute to the growth of the human microbiome market. Increasing side effects and diminishing of human gut flora, due to excessive use of antibiotics, is likely to drive the growth of the human microbiome market. The application market is also expected to be a prominent segment owing to the use of microbiome as diagnostics and therapeutics. The evidence from intransigent research resulted the use of microbiomes as biomarkers and diagnosis of various diseases.
The disease segment, on the other hand, will be the fastest-growing segment in the coming years. With the growing incidences and increasing awareness of lifestyle diseases this market is set to grow at a fast pace.
The grey area while estimating the market size was the uncertainty factor that lies with the current regulatory scenario for various products. The insights were provided by the industry experts who later clarified as to which disease segment will witness product approvals by the regulatory authorities and will enter the market in the future.
From an insight perspective, this research report focuses on the qualitative data, future market size, share, and market potential of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats) and technological trends, globally. It mainly focuses on the emerging and high-growth segments of the human microbiome market and the initiatives of their respective governments.
The competitive landscape covers the current product pipelines of the industry players in various stages of the clinical trial development. The company profiles comprise the basic views on the key players in the human microbiome market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future.
The above mentioned market research data, market potential, future market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding market penetration, product development/innovation, market development, market diversification, and competitive assessment, product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful in the market.
”
“TABLE OF CONTENTS
1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 MARKET SIZE ESTIMATION 20
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 23
2.2.1 KEY DATA FROM SECONDARY SOURCES 24
2.2.2 KEY DATA FROM PRIMARY SOURCES 24
2.2.3 KEY INDUSTRY INSIGHTS 25
2.2.4 ASSUMPTIONS 25
3 EXECUTIVE SUMMARY 26
4 PREMIUM INSIGHTS 31
4.1 HUMAN MICROBIOME MARKET OVERVIEW 31
4.2 GEOGRAPHIC ANALYSIS: HUMAN MICROBIOME MARKET, BY PRODUCT 32
4.3 GEOGRAPHIC SNAPSHOT OF THE HUMAN MICROBIOME MARKET 33
4.4 HUMAN MICROBIOME MARKET, BY PRODUCT, 2019 VS. 2023 33
4.5 HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY, 2015 VS. 2020 34
4.6 LIFE CYCLE ANALYSIS 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 36
5.2 MARKET SEGMENTATION 36
5.3 MARKET DYNAMICS 37
5.3.1 DRIVERS 37
5.3.1.1 Human microbiome therapy, an emerging market 37
5.3.1.2 Human microbiome as a new validated target 38
5.3.1.3 Need for early disease detection and diagnosis driving the use of microbiomes in molecular diagnostics 38
5.3.2 RESTRAINTS 39
5.3.2.1 Lack of expertise, proper detailed research 39
5.3.2.2 Barriers to prove causal link between dysbiosis and disease 39
5.3.3 OPPORTUNITIES 40
5.3.3.1 Investigational New Drug (IND) requirements for fecal microbiota may boost market growth 40
5.3.3.2 Joint ventures, collaborations, & partnerships 40
5.3.4 THREATS 41
5.3.4.1 Government regulations 41
5.3.5 BURNING ISSUES 42
5.3.5.1 Abundant opportunities in the microbiome field and tremendous research investments 42
5.3.5.2 Development of microbiome therapeutic products 43
6 HUMAN MICROBIOME MARKET, BY PRODUCT 44
6.1 INTRODUCTION 45
6.2 PROBIOTICS 46
6.3 FOODS 48
6.4 PREBIOTICS 49
6.5 MEDICAL FOODS 50
6.6 DIAGNOSTIC DEVICES 51
6.7 DRUGS 52
6.8 OTHER PROBIOTIC SUPPLEMENTS 53
7 HUMAN MICROBIOME MARKET, BY APPLICATION 54
7.1 INTRODUCTION 55
7.2 THERAPEUTICS 56
7.3 DIAGNOSTICS 57
8 HUMAN MICROBIOME MARKET, BY DISEASE 59
8.1 INTRODUCTION 60
8.2 ACUTE DIARRHEA 62
8.3 OBESITY 63
8.4 DIABETES 65
8.5 AUTOIMMUNE DISORDERS 66
8.6 CANCER 67
8.7 MENTAL DISORDERS 68
8.8 OTHER DISEASES 69
9 HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY PRODUCT 70
9.1 INTRODUCTION 71
9.2 INSTRUMENTS 72
9.2.1 LABORATORY INSTRUMENTS 74
9.2.2 ANALYZERS 75
9.3 CONSUMABLES 76
9.3.1 KITS 78
9.3.2 REAGENTS 79
10 HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY 80
10.1 INTRODUCTION 81
10.2 CELL CULTURE TECHNOLOGY 82
10.3 HIGH-THROUGHPUT TECHNOLOGY 83
10.4 OMICS TECHNOLOGY 85
10.5 COMPUTATIONAL TOOLS 86
11 GEOGRAPHIC ANALYSIS 88
11.1 INTRODUCTION 89
11.2 NORTH AMERICA 91
11.2.1 U.S. 95
11.2.2 CANADA 97
11.3 EUROPE 99
11.4 ASIA-PACIFIC 103
11.5 REST OF THE WORLD (ROW) 108
12 COMPETITIVE LANDSCAPE 112
12.1 OVERVIEW 113
12.2 COMPETITIVE SITUATION AND TRENDS 114
12.2.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 115
12.2.2 ACQUISITIONS & EXPANSIONS 116
12.2.3 NEW PRODUCT LAUNCHES, PRODUCT APPROVALS, AND PATENTS 117
12.2.4 OTHER DEVELOPMENTS 118
13 COMPANY PROFILES 119
(Overview, Financials, Products & Services, Strategy, & Developments)*
13.1 GEOGRAPHIC REVENUE MIX OF THE THREE MARKET PLAYERS 119
13.2 ENTEROME BIOSCIENCE 120
13.3 E.I. DU PONT DE NEMOURS AND COMPANY 123
13.4 MERCK & CO., INC. 126
13.5 METABIOMICS CORPORATION 128
13.6 YAKULT HONSHA CO., LTD. 130
13.7 MICROBIOME THERAPEUTICS, LLC 133
13.8 OSEL, INC. 135
13.9 SECOND GENOME, INC. 136
13.10 VITHERA PHARMACEUTICALS 138
13.11 VEDANTA BIOSCIENCES, INC. 139
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
14 APPENDIX 140
14.1 INSIGHTS OF INDUSTRY EXPERTS 140
14.2 DISCUSSION GUIDE 141
14.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 144
14.4 AVAILABLE CUSTOMIZATIONS 145
14.5 RELATED REPORTS 146
“
“LIST OF TABLES
TABLE 1 USE OF MICROBIOME IN EARLY DISEASE DETECTION AND DIAGNOSIS, A KEY DRIVER TO THE GROWTH OF THE MARKET 38
TABLE 2 LACK OF PROPER DETAILED RESEARCH CURBS MARKET GROWTH 40
TABLE 3 SIGNIFICANT IMPACT OF REGULATORY AUTHORITIES MAY BOOST MARKET GROWTH 41
TABLE 4 MODIFICATION OF REGULATORY PATHWAYS BY THE FDA MAY HAMPER THE GROWTH OF THE MARKET 42
TABLE 5 HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019–2023 (USD MILLION) 46
TABLE 6 HUMAN MICROBIOME MARKET SIZE FOR PROBIOTICS, BY REGION,
2019-2023 (USD MILLION) 47
TABLE 7 HUMAN MICROBIOME FOODS MARKET, BY REGION, 2019-2023 (USD MILLION) 48
TABLE 8 HUMAN MICROBIOME MARKET SIZE FOR PREBIOTICS, BY REGION,
2019-2023 (USD MILLION) 49
TABLE 9 HUMAN MICROBIOME MARKET SIZE FOR MEDICAL FOODS, BY REGION,
2019-2023 (USD MILLION) 50
TABLE 10 HUMAN MICROBIOME MARKET SIZE FOR DIAGNOSTIC DEVICES,
BY REGION, 2019–2023 (USD MILLION) 51
TABLE 11 HUMAN MICROBIOME MARKET SIZE FOR DRUGS, BY REGION,
2019–2023 (USD MILLION) 52
TABLE 12 HUMAN MICROBIOME MARKET SIZE FOR OTHER PROBIOTIC SUPPLEMENTS,
BY REGION, 2019-2023 (USD MILLION) 53
TABLE 13 HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019–2023 (USD MILLION) 55
TABLE 14 HUMAN MICROBIOME MARKET SIZE FOR THERAPEUTIC APPLICATIONS,
BY REGION, 2019–2023 (USD MILLION) 57
TABLE 15 HUMAN MICROBIOME MARKET SIZE FOR DIAGNOSTIC APPLICATIONS,
BY REGION, 2019–2023 (USD MILLION) 58
TABLE 16 HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019–2023 (USD MILLION) 61
TABLE 17 HUMAN MICROBIOME MARKET SIZE FOR ACUTE DIARRHEA, BY REGION,
2019–2023 (USD MILLION) 63
TABLE 18 HUMAN MICROBIOME MARKET SIZE FOR OBESITY, BY REGION,
2019–2023 (USD MILLION) 64
TABLE 19 HUMAN MICROBIOME MARKET SIZE FOR DIABETES, BY REGION,
2019–2023 (USD MILLION) 65
TABLE 20 HUMAN MICROBIOME MARKET SIZE FOR AUTOIMMUNE DISORDERS,
BY REGION, 2019–2023 (USD MILLION) 66
TABLE 21 HUMAN MICROBIOME MARKET SIZE FOR CANCER, BY REGION,
2019–2023 (USD MILLION) 67
TABLE 22 HUMAN MICROBIOME MARKET SIZE FOR MENTAL DISORDERS,
BY REGION, 2019–2023 (USD MILLION) 68
TABLE 23 HUMAN MICROBIOME MARKET SIZE FOR OTHER DISEASES,
BY REGION, 2019–2023 (USD MILLION) 69
TABLE 24 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY PRODUCT, 2013–2020 (USD MILLION) 71
TABLE 25 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS,
BY TYPE, 2013–2020 (USD MILLION) 72
TABLE 26 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS,
BY REGION, 2013–2020 (USD MILLION) 73
TABLE 27 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY COUNTRY, 2013–2020 (USD MILLION) 73
TABLE 28 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR LABORATORY INSTRUMENTS, BY REGION, 2013–2020 (USD MILLION) 74
TABLE 29 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2013–2020 (USD MILLION) 75
TABLE 30 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR ANALYZERS,
BY REGION, 2013–2020 (USD MILLION) 75
TABLE 31 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR ANALYZERS, BY COUNTRY, 2013–2020 (USD MILLION) 76
TABLE 32 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013–2020 (USD MILLION) 77
TABLE 33 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY REGION, 2013–2020 (USD MILLION) 77
TABLE 34 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY COUNTRY, 2013–2020 (USD MILLION) 77
TABLE 35 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR KITS, BY REGION, 2013–2020 (USD MILLION) 78
TABLE 36 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR KITS, BY COUNTRY, 2013–2020 (USD MILLION) 78
TABLE 37 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR REAGENTS,
BY REGION, 2013–2020 (USD MILLION) 79
TABLE 38 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR REAGENTS, BY COUNTRY, 2013–2020 (USD MILLION) 79
TABLE 39 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY TECHNOLOGY, 2013–2020 (USD MILLION) 81
TABLE 40 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CELL CULTURE TECHNOLOGY, BY REGION, 2013–2020 (USD MILLION) 82
TABLE 41 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CELL CULTURE TECHNOLOGY, BY COUNTRY, 2013–2020 (USD MILLION) 83
TABLE 42 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2013–2020 (USD MILLION) 83
TABLE 43 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR HIGH-THROUGHPUT TECHNOLOGY, BY COUNTRY, 2013–2020 (USD MILLION) 84
TABLE 44 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR OMICS TECHNOLOGY, BY REGION, 2013–2020 (USD MILLION) 85
TABLE 45 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR OMICS TECHNOLOGY, BY COUNTRY, 2013–2020 (USD MILLION) 86
TABLE 46 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR COMPUTATIONAL TOOLS, BY REGION, 2013–2020 (USD MILLION) 87
TABLE 47 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR COMPUTATIONAL TOOLS, BY COUNTRY, 2013–2020 (USD MILLION) 87
TABLE 48 HUMAN MICROBIOME MARKET SIZE, BY REGION, 2019–2023 (USD MILLION) 90
TABLE 49 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 90
TABLE 50 NORTH AMERICA: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT,
2019–2023 (USD MILLION) 92
TABLE 51 NORTH AMERICA: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION,
2019–2023 (USD MILLION) 93
TABLE 52 NORTH AMERICA: HUMAN MICROBIOME MARKET SIZE, BY DISEASE,
2019–2023 (USD MILLION) 93
TABLE 53 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY PRODUCT, 2013–2020 (USD MILLION) 94
TABLE 54 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013–2020 (USD MILLION) 94
TABLE 55 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013–2020 (USD MILLION) 94
TABLE 56 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY TECHNOLOGY, 2013–2020 (USD MILLION) 95
TABLE 57 U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY PRODUCT, 2013–2020 (USD MILLION) 95
TABLE 58 U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013–2020 (USD MILLION) 96
TABLE 59 U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013–2020 (USD MILLION) 96
TABLE 60 U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY TECHNOLOGY, 2013–2020 (USD MILLION) 96
TABLE 61 CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY PRODUCT, 2013–2020 (USD MILLION) 97
TABLE 62 CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013–2020 (USD MILLION) 97
TABLE 63 CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013–2020 (USD MILLION) 98
TABLE 64 CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY TECHNOLOGY, 2013–2020 (USD MILLION) 98
TABLE 65 EUROPE: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT,
2019–2023 (USD MILLION) 100
TABLE 66 EUROPE: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION,
2019–2023 (USD MILLION) 100
TABLE 67 EUROPE: HUMAN MICROBIOME MARKET SIZE, BY DISEASE,
2019–2023 (USD MILLION) 101
TABLE 68 EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY PRODUCT, 2013–2020 (USD MILLION) 101
TABLE 69 EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013–2020 (USD MILLION) 102
TABLE 70 EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013–2020 (USD MILLION) 102
TABLE 71 EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY TECHNOLOGY, 2013–2020 (USD MILLION) 102
TABLE 72 ASIA-PACIFIC: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT,
2019–2023 (USD MILLION) 104
TABLE 73 ASIA-PACIFIC: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION,
2019–2023 (USD MILLION) 105
TABLE 74 ASIA-PACIFIC: HUMAN MICROBIOME MARKET SIZE, BY DISEASE,
2019–2023 (USD MILLION) 105
TABLE 75 APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY PRODUCT, 2013–2020 (USD MILLION) 106
TABLE 76 APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013–2020 (USD MILLION) 106
TABLE 77 APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013–2020 (USD MILLION) 106
TABLE 78 APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY TECHNOLOGY, 2013–2020 (USD MILLION) 107
TABLE 79 ROW: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT,
2019–2023 (USD MILLION) 108
TABLE 80 ROW: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION,
2019–2023 (USD MILLION) 108
TABLE 81 ROW: HUMAN MICROBIOME MARKET SIZE, BY DISEASE,
2019–2023 (USD MILLION) 109
TABLE 82 ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY PRODUCT, 2013–2020 (USD MILLION) 109
TABLE 83 ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013–2020 (USD MILLION) 110
TABLE 84 ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013–2020 (USD MILLION) 110
TABLE 85 ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY TECHNOLOGY, 2013–2020 (USD MILLION) 111
TABLE 86 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS , 2012–2015 115
TABLE 87 ACQUISITIONS & EXPANSIONS, 2012-2015 116
TABLE 88 NEW PRODUCT LAUNCHES, PRODUCT APPROVALS, AND PATENTS, 2012–2015 117
TABLE 89 OTHER DEVELOPMENTS, 2012–2015 118
“
“LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 19
FIGURE 2 MARKET SIZE ESTIMATION AND DATA TRIANGULATION BOTTOM-UP APPROACH 21
FIGURE 3 TOP-DOWN APPROACH 21
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 22
FIGURE 5 HUMAN MICROBIOME MARKET SNAPSHOT (2019 VS. 2023) 26
FIGURE 6 PROBIOTICS SEGMENT TO DOMINATE THE HUMAN MICROBIOME MARKET DURING THE FORECAST PERIOD 27
FIGURE 7 CONSUMABLES SEGMENT TO WITNESS THE HIGHEST GROWTH RATE IN THE MICROBIOME RESEARCH SPENDING MARKET FROM 2015 TO 2020 28
FIGURE 8 CELL CULTURE TECHNOLOGIES TO DOMINATE THE HUMAN MICROBIOME RESEARCH SPENDING MARKET IN 2015 28
FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL HUMAN MICROBIOME MARKET, 2019 29
FIGURE 10 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS – DOMINANT STRATEGY PURSUED BY MARKET PLAYERS 30
FIGURE 11 GROWING PREVALENCE OF LIFESTYLE DISEASES AND INCREASING ACCEPTANCE OF MICROBIOME-BASED PRODUCTS ARE MAJOR GROWTH DRIVERS 31
FIGURE 12 PR0BIOTICS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET
IN 2019 32
FIGURE 13 NORTH AMERICA POISED TO BE THE FASTEST-GROWING MARKET FROM
2019 TO 2023 33
FIGURE 14 PREBIOTICS SEGMENT POISED TO GROW AT THE HIGHEST CAGR FROM
2019 TO 2023 33
FIGURE 15 CELL CULTURE TECHNOLOGIES SEGMENT TO DOMINATE THE MICROBIOME RESEARCH SPENDING TECHNOLOGY MARKET IN 2015 34
FIGURE 16 NORTH AMERICA TO ENTER EXPONENTIAL GROWTH PHASE 34
FIGURE 17 HUMAN MICROBIOME AS A NEW VALIDATED TARGET FOR DRUG DEVELOPMENT MAY SPUR THE MARKET 37
FIGURE 18 FUNDS PROVIDED FOR MICROBIOME RESEARCH BY VARIOUS MEDICAL RESEARCH AGENCIES 42
FIGURE 19 PROBIOTICS EXPECTED TO DOMINATE THE HUMAN MICROBIOME MARKET DURING THE FORECAST PERIOD 45
FIGURE 20 EUROPE WILL ACCOUNT FOR THE LARGEST SHARE OF THE PROBIOTICS MARKET IN 2019 47
FIGURE 21 NORTH AMERICA EXPECTED TO DOMINATE THE HUMAN MICROBIOME FOODS MARKET FROM 2019 TO 2023 48
FIGURE 22 INORGANIC GROWTH STRATEGIES BETWEEN COMPANIES WILL INCREASE THE DEMAND FOR MICROBIOME-BASED DRUGS IN EUROPE 52
FIGURE 23 THE THERAPEUTICS SEGMENT TO COMMAND THE LARGEST SHARE OF THE HUMAN MICROBIOME APPLICATIONS MARKET BY 2023 55
FIGURE 24 EUROPE TO ACCOUNT FOR THE LARGEST SHARE OF THE THERAPEUTICS APPLICATION SEGMENT IN 2019 56
FIGURE 25 ACUTE DIARRHEA EXPECTED TO BE THE LARGEST DISEASE SEGMENT OF THE HUMAN MICROBIOME MARKET IN 2019 60
FIGURE 26 EUROPE IS ESTIMATED TO BE THE LARGEST HUMAN MICROBIOME MARKET FOR ACUTE DIARRHEA IN 2019 62
FIGURE 27 HUMAN MICROBIOME MARKET FOR OBESITY IS EXPECTED TO WITNESS HIGHEST GROWTH RATE IN NORTH AMERICA DURING THE FORECAST PERIOD 64
FIGURE 28 INSTRUMENTS SEGMENT TO DOMINATE THE HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY PRODUCT 71
FIGURE 29 EUROPE TO ACCOUNT FOR THE LARGEST SHARE OF THE INSTRUMENTS SEGMENT IN 2015 72
FIGURE 30 NORTH AMERICA TO WITNESS THE HIGHEST GROWTH IN THE CONSUMABLES MARKET FROM 2015 TO 2020 76
FIGURE 31 CELL CULTURE TECHNOLOGY SEGMENT TO GROW AT THE HIGHEST RATE FROM 2015 TO 2020 81
FIGURE 32 EUROPE TO ACCOUNT FOR THE LARGEST SHARE OF THE CELL CULTURE TECHNOLOGY SEGMENT IN 2015 82
FIGURE 33 U.S. TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN HIGH-THROUGHPUT TECHNOLOGY MARKET BY 2020 84
FIGURE 34 CANADA TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 85
FIGURE 35 NORTH AMERICA WILL BE THE FASTED-GROWING REGION IN THE COMPUTATIONAL TOOLS MARKET FROM 2015 TO 2020 86
FIGURE 36 GEOGRAPHIC SNAPSHOT (2019): NORTH AMERICA WILL BE THE FASTEST-GROWING REGION BY 2019 89
FIGURE 37 NORTH AMERICA SHOWS HIGH GROWTH POTENTIAL FOR THE HUMAN MICROBIOME RESEARCH SPENDING MARKET 90
FIGURE 38 DEMAND FOR HUMAN MICROBIOME WILL BE FUELED BY GROWING R&D AND RISING INCIDENCES OF LIFESTYLE DISEASES AND CHRONIC DISORDERS 91
FIGURE 39 EUROPE: MARKET SNAPSHOT 99
FIGURE 40 PREBIOTICS SEGMENT TO GROW AT THE FASTEST RATE IN THE APAC HUMAN MICROBIOME PRODUCT MARKET FROM 2019 TO 2023 104
FIGURE 41 CELL CULTURE TECHNOLOGY IS THE MOST COMMONLY USED TECHNOLOGY FOR HUMAN MICROBIOME RESEARCH IN 2015 111
FIGURE 42 COMPANIES ADOPTED AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS AS THEIR KEY GROWTH STRATEGY OVER THE LAST THREE YEARS 113
FIGURE 43 BATTLE FOR MARKET SHARE: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS – KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE HUMAN MICROBIOME MARKET 114
FIGURE 44 E.I. DU PONT DE NEMOURS AND COMPANY: COMPANY SNAPSHOT 123
FIGURE 45 MERCK & CO., INC.: COMPANY SNAPSHOT 126
FIGURE 46 YAKULT HONSHA CO., LTD.: COMPANY SNAPSHOT 130
“
